| 摘要 |
The present invention relates to crystalline eltrombopag Forms I, III, V, XVI, the use of said crystalline forms for preparing eltrombopag ethanolamine salt, a process for preparing eltrombopag ethanolamine salt, a pharmaceutical composition for treating conditions leading to thrombocytopenia, the use of said crystalline forms as a pharmaceutical composition for treating conditions leading to thrombocytopenia, the use of said polymorph forms for the manufacture of a medicament for treating conditions leading to thrombocytopenia. |
